{"id":"doi:10.4103/1673-5374.340409","kind":"article","title":"Initial failures of anti-tau antibodies in Alzheimer’s disease are reminiscent of the amyloid-β story","authors":["Bruno Pietro Imbimbo","Claudia Balducci","Stefania Ippati","Mark Watling"],"author_count":4,"year":2022,"published":"2022-05-06","venue":"Neural Regeneration Research","cited_by":61,"doi":"10.4103/1673-5374.340409","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.4103/1673-5374.340409","archive_url":"https://space-kitty.com/papers/doi:10.4103/1673-5374.340409","updated":null,"pmid":"35799522","pmcid":null,"openalex_id":"W4229000412","pdf_url":null,"abstract":null,"abstract_license":null,"license":"cc-by-nc-sa","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Alzheimer's disease research and treatments"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","domain_slug":"medicine"}],"cited_in_dossiers":[]}